Category Archives: Press Releases

You are here:

Home
Category "Press Releases"

Daily aspirin not protective against depression in ASPREE trial

By Trish Announcement ASPREE Sub-Studies Press Releases

ASPREE’s sub-study, ASPREE-D (depression) publishes findings on effect of daily low dose aspirin on prevention of depression. PRESS RELEASE: 4th June 2020 – Taking low dose aspirin daily does not prevent depression in healthy older adults, according to collaborative researchers at the Institute for Mental and Physical Health and Clinical Translation (IMPACT) and the ASPREE (ASPirin in Reducing Events in the Elderly) Clinical Trial.

04/06/2020

Details

ASPREE trial shows aspirin does not prevent cognitive decline in healthy elderly

By Trish aspirin research ASPREE elderly Press Releases

Landmark trial shows aspirin does not prevent cognitive decline in healthy elderly PRESS RELEASE: 1st April 2020 – Melbourne Researchers at Monash University and the Berman Center for Outcomes and Clinical Research in the US, have found that daily aspirin does not reduce the risk of Alzheimer’s disease, mild cognitive impairment, or cognitive decline…

01/04/2020

Details

World-first Aspirin Study Reaches Target

By Trish aspirin research ASPREE progress Press Releases

PRESS RELEASE: Melbourne, December 1, 2014 – Australia’s largest clinical trial is a step closer to revealing in 2018 whether healthy older people should or should not take aspirin to prevent or delay cardiovascular disease (heart attack and stroke), dementia, depression and some types of cancers. ASPREE (ASPirin in Reducing Events in the Elderly), a…

01/12/2014

Details

Aspirin Use to Prevent Cancer Draws Key Researchers to Symposium

By Trish aspirin research Press Releases

PRESS RELEASE: Melbourne, 20 October 2014: The use of aspirin to prevent cancer will be discussed by experts at a symposium in Melbourne today. Leading healthcare professionals will discuss the scientific evidence for and against the use of aspirin for the chemoprevention of cancer. With the rising importance of disease prevention, researchers are looking at…

20/10/2014

Details

When aspirin makes the news

By Trish aspirin in the media ASPREE response Press Releases

The Principal Investigator for the Australian arm of the ASPREE study, Professor John McNeil (pictured left), urges that reports on the benefits or the risks of daily aspirin in healthy people should be taken in context. “Most major health organisations will not ‘jump the gun’ and recommend aspirin to healthy people without evidence. They are not making…

30/05/2014

Details

Why leading health authorities cannot recommend aspirin for primary prevention

By Trish aspirin in the media Press Releases

Government and health authorities make recommendations based on scientific evidence that proves the benefit of a particular therapy outweighs the risks. All medications have side effects and low-dose aspirin is no exception. Aspirin is often prescribed for secondary prevention in people who have had a heart attack or stroke because research demonstrates that in this…

18/05/2014

Details

US Food and Drug Authority Stance Supports ASPREE

By Trish aspirin in the media Press Releases

The US Food and Drug Administration’s (FDA) decision not to recommend aspirin for primary prevention due to a lack of scientific evidence, adds further support for the ASPREE study. In a statement issued on their website, the FDA reported that the potential benefits of aspirin had not yet been established against known risks, such as…

08/05/2014

Details

ASPREE study updates begin in Shepparton

By Trish ASPREE study updates Press Releases

Senior researchers in the ASPREE (ASPirin in Reducing Events in the Elderly) trial were in Shepparton this week to give the first of several study updates planned for Australian participants this year. Executive Officer of ASPREE, Associate Professor Robyn Woods, presented an update on the aspirin study’s progress at a morning tea for participants living in…

25/03/2014

Details

The ASPREE study does not have preliminary findings

By Trish ASPREE progress Press Releases

The ASPREE study does not have preliminary findings at this point in time – the trial is still in the recruitment phase and will continue to be so until mid 2014. If you have further questions, please ring 1800 728 745 (toll free from a landline).

29/11/2013

ASPREE study launched in Wollongong

By Trish aspirin research ASPREE participants ASPREE study launch Press Releases

PRESS RELEASE Wollongong locals to participate in Australia’s largest primary prevention Aspirin Trial Wollongong, October 3, 2013 – The ASPREE (ASPirin in Reducing Events in the Elderly) study – the largest primary prevention aspirin study ever undertaken in older people – is calling on local residents from Wollongong and surrounding regions to participate in the study.…

03/10/2013

Details